Impact of Chemotherapeutic Stress Depends on The Nature of Breast Cancer Spheroid and Induce Behavioral Plasticity to Resistant Population
Source abstract
Abstract
Abstract Cellular or tumor dormancy, identified recently as one of the main reasons behind post‐therapy recurrence, can be caused by diverse reasons. Chemotherapy has recently been recognized as one of such reasons. However, in‐depth studies of chemotherapy‐induced dormancy are lacking due to the absence of an in vitro human‐relevant model tailor‐made for such a scenario. This report utilized multicellular breast cancer spheroid to create a primary platform for establishing a chemotherapy‐induced dormancy model. It is observed that extreme chemotherapeutic stress affects invasive and non‐invasive spheroids differently. Non‐invasive spheroids exhibit more resilience and maintain viability and migrational ability, while invasive spheroids display heightened susceptibility and improved tumorigenic capacity. Heterogenous spheroids exhibit increased tumorigenic capacity while show minimal survival ability. Further probing of chemotherapeutically dormant spheroids is needed to understand the molecular mechanism and identify dormancy‐related markers to achieve therapeutic success in the future.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cancer Cells and Metastasis · Cancer, Stress, Anesthesia, and Immune Response · Cancer-related cognitive impairment studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biotechnology (merged with Institute of Bioinformatics and Biotechnology) Savitribai Phule Pune University Pune 411007 India
References (99)
Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. Printz C. · Cancer · 2020 · 126 · 160
3. 10.1111/j.1600-0463.2008.01077.x10.1111/j.1600-0463.2008.01077.x ↗
4. 10.1016/j.cub.2016.11.05710.1016/j.cub.2016.11.057 ↗
5. 10.3389/fcell.2018.0001710.3389/fcell.2018.00017 ↗
6. 10.1007/s10585-017-9870-x10.1007/s10585-017-9870-x ↗
7. 10.1080/2162402X.2019.159600410.1080/2162402X.2019.1596004 ↗
8. 10.1186/s12885-020-07376-110.1186/s12885-020-07376-1 ↗
9. 10.1158/1078-0432.CCR-10-257410.1158/1078-0432.CCR-10-2574 ↗
10. 10.1038/nrc293310.1038/nrc2933 ↗
11. 10.1111/febs.1562610.1111/febs.15626 ↗
12. 10.1023/A:100588742202210.1023/A:1005887422022 ↗
13. 10.1038/ncb276710.1038/ncb2767 ↗
14. 10.1038/sj.onc.120912210.1038/sj.onc.1209122 ↗
15. 10.1073/pnas.110963210810.1073/pnas.1109632108 ↗
16. 10.1016/j.ccr.2004.06.02510.1016/j.ccr.2004.06.025 ↗
17. 10.1158/0008-5472.CAN-04-445810.1158/0008-5472.CAN-04-4458 ↗
18. 10.1007/s10585-008-9201-310.1007/s10585-008-9201-3 ↗
19. 10.1016/j.addr.2014.10.01510.1016/j.addr.2014.10.015 ↗
20. 10.1158/0008-5472.CAN-13-099110.1158/0008-5472.CAN-13-0991 ↗
21. 10.1007/s10585-015-9710-910.1007/s10585-015-9710-9 ↗
22. 10.1038/bjc.2014.53310.1038/bjc.2014.533 ↗
23. 10.1016/j.actbio.2020.02.03910.1016/j.actbio.2020.02.039 ↗
24. 10.1002/adhm.20160068410.1002/adhm.201600684 ↗
25. 10.1158/0008-5472.CAN-18-092710.1158/0008-5472.CAN-18-0927 ↗
26. 10.1038/s41523-021-00269-x10.1038/s41523-021-00269-x ↗
27. 10.3389/fcell.2020.0003710.3389/fcell.2020.00037 ↗
28. 10.1186/s12935-021-01853-810.1186/s12935-021-01853-8 ↗
29. 10.1155/2012/83205910.1155/2012/832059 ↗
30. 10.1016/0065-2571(84)90007-410.1016/0065-2571(84)90007-4 ↗
31. 10.1016/j.celrep.2019.10.06310.1016/j.celrep.2019.10.063 ↗
32. 10.1039/C5PY01841B10.1039/C5PY01841B ↗
33. 10.3402/nano.v6.2829710.3402/nano.v6.28297 ↗
34. 10.1371/journal.pone.002610010.1371/journal.pone.0026100 ↗
35. 10.1016/j.canlet.2019.08.00410.1016/j.canlet.2019.08.004 ↗
36. 10.20517/2394-4722.2019.1610.20517/2394-4722.2019.16 ↗
37. 10.1016/j.omtn.2021.07.01910.1016/j.omtn.2021.07.019 ↗
38. 10.1038/nrc397110.1038/nrc3971 ↗
39. 10.1073/pnas.090933310710.1073/pnas.0909333107 ↗
40. 10.1016/j.canlet.2010.09.00510.1016/j.canlet.2010.09.005 ↗
41. 10.1007/s10549-017-4532-x10.1007/s10549-017-4532-x ↗
42. 10.3892/or.2013.285110.3892/or.2013.2851 ↗
43. 10.1038/srep1562310.1038/srep15623 ↗
44. 10.1038/srep0952910.1038/srep09529 ↗
45. 10.1038/nrc397110.1038/nrc3971 ↗
46. 10.7150/jca.766810.7150/jca.7668 ↗
47. 10.1007/BF0066580510.1007/BF00665805 ↗
48. 10.1002/jcb.2115310.1002/jcb.21153 ↗
49. 10.1038/cr.2014.13810.1038/cr.2014.138 ↗
50. 10.1038/s41598-021-84406-310.1038/s41598-021-84406-3 ↗
51. 10.1186/s12935-015-0200-610.1186/s12935-015-0200-6 ↗
52. 10.3389/fcell.2021.58357210.3389/fcell.2021.583572 ↗
53. Ivascu A. · Int J Oncol · 2007 · 31 · 1403
54. 10.1038/srep1562310.1038/srep15623 ↗
55. 10.1016/j.bcp.2008.03.01610.1016/j.bcp.2008.03.016 ↗
56. Yang N. J. · 2015 · 1266
57. 10.1016/j.xphs.2017.02.02310.1016/j.xphs.2017.02.023 ↗
58. 10.1038/s41598-017-06445-z10.1038/s41598-017-06445-z ↗
59. 10.1016/j.ijpharm.2020.11922210.1016/j.ijpharm.2020.119222 ↗
60. 10.1007/s12307-015-0171-010.1007/s12307-015-0171-0 ↗
61. 10.1016/j.biopha.2021.11153610.1016/j.biopha.2021.111536 ↗
62. Kim N.‐G. · PNAC. · 2011 · 108 · 1193
63. 10.1073/pnas.170309611410.1073/pnas.1703096114 ↗
64. 10.1021/bi971804310.1021/bi9718043 ↗
65. 10.1007/978-1-4615-4811-9_1810.1007/978-1-4615-4811-9_18 ↗
66. 10.1371/journal.pone.006033410.1371/journal.pone.0060334 ↗
67. 10.1038/nrclinonc.2016.12810.1038/nrclinonc.2016.128 ↗
68. Furger K. A. · Mol. Cancer Res. · 2003 · 1 · 810
69. 10.1002/ijc.3235910.1002/ijc.32359 ↗
70. 10.4161/cam.5.5.1794910.4161/cam.5.5.17949 ↗
71. 10.1111/j.1349-7006.2008.00876.x10.1111/j.1349-7006.2008.00876.x ↗
72. Che C.‐L. · Int. J. Clin. Exp. Pathol. · 2013 · 6 · 1538
73. 10.4048/jbc.2019.22.e2210.4048/jbc.2019.22.e22 ↗
74. 10.1371/journal.pone.009802110.1371/journal.pone.0098021 ↗
75. 10.1371/journal.pone.003556910.1371/journal.pone.0035569 ↗
76. 10.1186/s13058-020-01357-910.1186/s13058-020-01357-9 ↗
77. 10.1016/j.celrep.2018.06.11010.1016/j.celrep.2018.06.110 ↗
78. 10.1073/pnas.211104611810.1073/pnas.2111046118 ↗
79. 10.1158/1078-0432.CCR-17-254510.1158/1078-0432.CCR-17-2545 ↗
80. 10.4161/cc.2102110.4161/cc.21021 ↗
81. 10.1373/clinchem.2012.18465510.1373/clinchem.2012.184655 ↗
82. 10.1148/radiol.248107084610.1148/radiol.2481070846 ↗
83. 10.1038/s41416-018-0301-910.1038/s41416-018-0301-9 ↗
84. 10.1038/s41598-017-14340-w10.1038/s41598-017-14340-w ↗
85. 10.1038/s41598-018-19930-w10.1038/s41598-018-19930-w ↗
86. 10.1038/s41598-021-81701-x10.1038/s41598-021-81701-x ↗
87. 10.1038/s41598-017-10078-710.1038/s41598-017-10078-7 ↗
88. 10.1016/j.actbio.2021.10.03110.1016/j.actbio.2021.10.031 ↗
89. 10.1038/s42003-021-02417-210.1038/s42003-021-02417-2 ↗
90. 10.1007/s44164-021-00006-510.1007/s44164-021-00006-5 ↗
91. 10.1371/journal.pone.007728110.1371/journal.pone.0077281 ↗
92. 10.2165/00003495-199856060-0000610.2165/00003495-199856060-00006 ↗
93. 10.1038/nprot.2008.22610.1038/nprot.2008.226 ↗
94. M.Fitzpatrick Measuring cell fluorescence using ImageJ https://github.com/mfitzp/theolb/blob/master/imaging/measuring‐cell‐fluorescence‐using‐imagej.rst(accessed: June 2020).
95. 10.1002/0471142727.mb2806s11110.1002/0471142727.mb2806s111 ↗
96. Laroumanie F. · JOVE. · 2017 · 2017
97. 10.3389/fnana.2012.0002710.3389/fnana.2012.00027 ↗
98. 10.1016/j.bbamem.2018.03.00710.1016/j.bbamem.2018.03.007 ↗
99. Borowicz S. · J. Vis. Exp. · 2014